ArticleMolecular vision2025
Pseudomyopia and cycloplegic changes in young cynomolgus macaques.
Article in Molecular vision, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Primate eyes feature a physiologic accommodative system identical to that of humans. Nonetheless, their biometric changes before and after cycloplegia have not been investigated. In this study, we aimed to evaluate the characteristics of pseudomyopia and explore factors associated with cycloplegic changes in young cynomolgus macaques. Methods: Refractive and biometric measurements were performed on both eyes before and after cycloplegia in 88 cynomolgus macaques aged 3-6 years without ocular diseases. Pseudomyopia was defined as autorefraction-estimated noncycloplegic spherical equivalent (NSE) < -0.50 D and cycloplegic spherical equivalent (CSE) ≥ -0.50 D. Linear mixed models were established to identify factors associated with cycloplegic differences. Results: After excluding low-quality ophthalmic data, 149 eyes were included in the final analysis. The median NSE was -0.38 (interquartile range: -1.50, 0.25) D and the median CSE was 0.13 (-0.50, 0.90) D, exhibiting a robust Pearson's correlation coefficient of 0.89 (95% confidence interval: 0.78-0.92). Pseudomyopia was observed in 35 of the 149 eyes, with a greater hyperopic shift (median, 1.42 D) compared to that in non-myopic and true-myopic eyes (median, 0.50 D for both, p<0.001). Pseudomyopic eyes demonstrated active accommodation before cycloplegia and exhibited biometric changes after cycloplegia akin to those in true-myopic eyes. Under cycloplegia, non-myopic and pseudomyopic eyes exhibited similar biometric measurements. A greater hyperopic shift correlated with a higher hyperopic NSE and greater reductions in lens thickness. Conclusions: The use of 1% cyclopentolate yielded discernible alterations in refractive and biometric parameters in 3- to 6-year-old cynomolgus macaques. Notably, compared with non-myopia and true myopia, pseudomyopia exhibited associations and discrepancies in accommodative status. These findings underscore the importance of investigating the role of the lens in animal models employed in myopia research.
Indexed as
Identifiers
41867375PMC13002936What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.